Inventor · disambiguated record
Magali Irla
Also filed as: IRLA MAGALI
4 granted patents·3 pending applications·1 citations·filing 2018–2024
59Inventor score
Files withINST NAT SANTE RECH MED7
Top patents by PatentIndex Score
7 records- 0175US11618884B2Regulatory T cells genetically modified for the lymphotoxin alpha gene and uses thereofINST NAT SANTE RECH MED·Filed 2018·Granted Apr 4, 2023·1 cites·9 claims
- 0270US12325735B2Regulatory T cells genetically modified for the lymphotoxin alpha gene and uses thereofINST NAT SANTE RECH MED·Filed 2023·Granted Jun 10, 2025·0 cites·2 claims
- 0369US2025034230A1Regulatory t cells targeted by lymphotoxin alpha blocking agent and uses thereofINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0458US12146160B2Regulatory T cells targeted by lymphotoxin alpha blocking agent and uses thereofINST NAT SANTE RECH MED·Filed 2020·Granted Nov 19, 2024·0 cites·7 claims
- 0555US2025025532A1Methods of boosting thymic regeneration in patients suffering from a thymic injury by using ranklINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0653US2022265768A1Methods of boosting thymic regeneration in patients suffering from a thymic injury by using ranklINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0743US11351226B2Methods of boosting thymic regeneration in patients suffering from a thymic injury by using RANKLINST NAT SANTE RECH MED·Filed 2018·Granted Jun 7, 2022·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Magali Irla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →